RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Cerevel Therapeutics Holdings Stock

Cerevel Therapeutics Holdings Liabilities 2024

Cerevel Therapeutics Holdings Liabilities

569.55 M USD

Ticker

CERE

ISIN

US15678U1280

WKN

A2QF3L

In 2024, Cerevel Therapeutics Holdings's total liabilities amounted to 569.55 M USD, a 14.69% difference from the 496.6 M USD total liabilities in the previous year.

Cerevel Therapeutics Holdings Aktienanalyse

What does Cerevel Therapeutics Holdings do?

Cerevel Therapeutics Holdings ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Liabilities Details

Assessing Cerevel Therapeutics Holdings's Liabilities

Cerevel Therapeutics Holdings's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Cerevel Therapeutics Holdings's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Cerevel Therapeutics Holdings's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Cerevel Therapeutics Holdings's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Cerevel Therapeutics Holdings’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Cerevel Therapeutics Holdings stock

What is the level of liabilities of Cerevel Therapeutics Holdings this year?

Cerevel Therapeutics Holdings has a debt balance of 569.55 M USD this year.

What were the liabilities of Cerevel Therapeutics Holdings compared to the previous year?

The liabilities of Cerevel Therapeutics Holdings have increased by 14.69% increased compared to the previous year.

What are the consequences of high debt for investors of Cerevel Therapeutics Holdings?

High liabilities can pose a risk for investors of Cerevel Therapeutics Holdings, as they can weaken the company's financial position and impair its ability to meet its obligations.

What consequences do low liabilities have for investors in Cerevel Therapeutics Holdings?

Low liabilities mean that Cerevel Therapeutics Holdings has a strong financial position and is able to meet its obligations without overburdening its finances.

How does an increase in liabilities of Cerevel Therapeutics Holdings affect the company?

An increase in liabilities of Cerevel Therapeutics Holdings can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.

How does a reduction in the liabilities of Cerevel Therapeutics Holdings affect the company?

A decrease in the liabilities of Cerevel Therapeutics Holdings can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.

What are some factors that influence the liabilities of Cerevel Therapeutics Holdings?

Some factors that can influence the liabilities of Cerevel Therapeutics Holdings include investments, acquisitions, operating costs, and sales development.

Why is the level of liabilities of Cerevel Therapeutics Holdings so important for investors?

The liabilities of Cerevel Therapeutics Holdings are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.

What strategic measures can Cerevel Therapeutics Holdings take to modify the liabilities?

To change its liabilities, Cerevel Therapeutics Holdings can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.

How much dividend does Cerevel Therapeutics Holdings pay?

Over the past 12 months, Cerevel Therapeutics Holdings paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Cerevel Therapeutics Holdings is expected to pay a dividend of 0 USD.

What is the dividend yield of Cerevel Therapeutics Holdings?

The current dividend yield of Cerevel Therapeutics Holdings is .

When does Cerevel Therapeutics Holdings pay dividends?

Cerevel Therapeutics Holdings pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Cerevel Therapeutics Holdings?

Cerevel Therapeutics Holdings paid dividends every year for the past 0 years.

What is the dividend of Cerevel Therapeutics Holdings?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Cerevel Therapeutics Holdings located?

Cerevel Therapeutics Holdings is assigned to the 'Health' sector.

Wann musste ich die Aktien von Cerevel Therapeutics Holdings kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Cerevel Therapeutics Holdings from 8/25/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 8/25/2024.

When did Cerevel Therapeutics Holdings pay the last dividend?

The last dividend was paid out on 8/25/2024.

What was the dividend of Cerevel Therapeutics Holdings in the year 2023?

In the year 2023, Cerevel Therapeutics Holdings distributed 0 USD as dividends.

In which currency does Cerevel Therapeutics Holdings pay out the dividend?

The dividends of Cerevel Therapeutics Holdings are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Cerevel Therapeutics Holdings

Our stock analysis for Cerevel Therapeutics Holdings Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Cerevel Therapeutics Holdings Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.